Patent-case verdict against Johnson & Johnson unit is overturned

04/5/2013 | Wall Street Journal, The

A $593 million patent-infringement ruling against Cordis, part of Johnson & Johnson, has been invalidated by an appeals court. The court found that a judge had misconstrued a patent held by a doctor. The doctor had brought lawsuits against Cordis and other companies that made heart stents.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Business

Job Title Company Location
Vice President, HEDIS & Performance Outcomes
Dayton, OH
Pharmacy Benefit Analyst/ Auditor
Nationwide, SL_Nationwide